These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25119692)

  • 1. Immunologic nonresponders and T-regulatory cells in HIV-1 infection.
    Suy F; Botelho-Nevers E; Gagneux-Brunon A; Frésard A; Paul S; Lambert C; Pozzetto B; Lucht F
    AIDS; 2013 Nov; 27(18):2968-71. PubMed ID: 25119692
    [No Abstract]   [Full Text] [Related]  

  • 2. Futility of CD4+ monitoring in HIV-1 patients with CD4+ cell count above 350 cells/μl on suppressive antiretroviral therapy.
    Duncan CJ; Schmid ML; Schwab U; Price DA; Ong E
    AIDS; 2014 Nov; 28(17):2638-9. PubMed ID: 25418545
    [No Abstract]   [Full Text] [Related]  

  • 3. Zero CD4 count: a case of discordant CD4 response in a patient with well suppressed viral load.
    Raja K; Chandrasekar C; Krishnarajasekhar OR; Manoharan G
    Indian J Med Microbiol; 2013; 31(3):298-302. PubMed ID: 23883722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
    Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
    HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy.
    Guzmán-Fulgencio M; Berenguer J; Micheloud D; Fernández-Rodríguez A; García-Álvarez M; Jiménez-Sousa MA; Bellón JM; Campos Y; Cosín J; Aldámiz-Echevarría T; Catalán P; López JC; Resino S
    J Antimicrob Chemother; 2013 Oct; 68(10):2349-57. PubMed ID: 23749950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS/HIV. Rekindled HIV infection.
    Siliciano JD; Siliciano RF
    Science; 2014 Aug; 345(6200):1005-6. PubMed ID: 25170139
    [No Abstract]   [Full Text] [Related]  

  • 9. MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection.
    Lugli E; Pinti M; Nasi M; Troiano L; Prada N; Mussini C; Borghi V; Esposito R; Cossarizza A
    Int J Immunogenet; 2005 Oct; 32(5):269-71. PubMed ID: 16164692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy.
    Hsu DC; Kerr SJ; Thongpaeng P; Iampornsin T; Pett SL; Zaunders JJ; Avihingsanon A; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA
    J Infect; 2014 Apr; 68(4):344-54. PubMed ID: 24325926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
    J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy.
    Gasser O; Brander C; Wolbers M; Brown NV; Rauch A; Günthard HF; Battegay M; Hess C;
    HIV Med; 2013 Apr; 14(4):241-6. PubMed ID: 22934786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.
    Killian MS; Fujimura SH; Hecht FM; Levy JA
    AIDS; 2006 Jun; 20(9):1247-52. PubMed ID: 16816552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of antiretroviral therapy in patients with a CD4 count of less than 350 cells: a retrospective audit against key indicators from the CQUIN payment framework.
    Mercer RM; Olarinde O; Ryan C; Greig J; Yeeles H; Walker A; Walker H; Meardon NC
    Int J STD AIDS; 2011 Dec; 22(12):755-6. PubMed ID: 22174062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.
    Harrer T; Plettenberg A; Arastéh K; Van Lunzen J; Fätkenheuer G; Jaeger H; Janssens M; Burny W; Collard A; Roman F; Loeliger A; Koutsoukos M; Bourguignon P; Lavreys L; Voss G
    Vaccine; 2014 May; 32(22):2657-65. PubMed ID: 24144472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption.
    Nemes E; Lugli E; Bertoncelli L; Nasi M; Pinti M; Manzini S; Prati F; Manzini L; Del Giovane C; D'Amico R; Cossarizza A; Mussini C
    AIDS; 2011 Jul; 25(12):1443-53. PubMed ID: 21505295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
    Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
    J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated CD57 and CD95 expressions are associated with lower numbers of CD4⁺ recent thymic emigrants in HIV-1 infected immune responders following antiretroviral treatment.
    Lu I; Eberhard J; Ahmad F; Bhatnagar N; Behrens G; Jacobs R; Schmidt RE; Meyer-Olson D
    Immunol Lett; 2014; 158(1-2):1-6. PubMed ID: 24291117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand.
    Chaiwarith R; Wachirakaphan C; Kotarathititum W; Praparatanaphan J; Sirisanthana T; Supparatpinyo K
    Int J Infect Dis; 2007 Sep; 11(5):413-6. PubMed ID: 17331776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of absolute CD4+ count in predicting co-infection with human T-lymphotropic virus type 1 in antiretroviral-naive HIV-infected patients.
    Gudo ES; Bhatt NB; Augusto O; Semá C; Savino W; Ferreira OC; Jani IV
    Int J STD AIDS; 2012 Oct; 23(10):717-23. PubMed ID: 23104746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.